Aptevo Therapeutics Inc. — Director's Dealing 2017

Dec 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2017-11-15

Reporting Person: Maddux Randy Joe (Senior VP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-15	Common Stock	P	25000	$2.76	Acquired	25000	Direct